Lebrikizumab治療中重度特應(yīng)性皮炎患者的Ⅲ期臨床研究
中國臨床藥理學(xué)雜志
頁數(shù): 1 2023-05-22
摘要: <正>引自:SILVERBERG J I,et al. Two phase 3 trials of lebrikizumab for moderate-to-severe atopic dermatitis[J]. N Engl J Med,2023,388(12):1080-1091.Lebrikizumab是一種新型單克隆抗體,可以高親和力結(jié)合白細(xì)胞介素(interleuk...